Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001415889-24-029682·CERO THERAPEUTICS HOLDINGS, INC.
Schedule 13G ownership disclosure
CERO THERAPEUTICS HLDGS INC
Common stock, par value $0.0001 per share · CUSIP: 71902K105
Event date: 2024-12-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- YK Bioventures Opportunities GP I, LLC
Shares: 17,002.00 · Class: 0.0%
- YK Bioventures Opportunities Fund I, L.P.
Shares: 17,002.00 · Class: 0.0%
- Gary K. Yeung
Shares: 17,002.00 · Class: 0.0%
- Mitchell W. Kossar
Shares: 17,002.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-24-029682
- Form type
- SCHEDULE 13G/A
- Filer
- CERO THERAPEUTICS HOLDINGS, INC.
- CIK
- CIK 1870404
- Filed
- Dec 17, 2024
- Reporting period
- Dec 13, 2024
- Description
- Schedule 13G beneficial ownership